Metronidazole Mercury Pharmaceuticals (Metronidazole)

Metronidazole enters anaerobic or microaerophilic cells and is reduced to reactive nitro radicals. These radicals damage microbial DNA and inhibit nucleic acid synthesis, leading to cell death. The drug’s selective activation in low‑oxygen environments provides targeted antimicrobial activity against the organisms that cause the skin conditions it treats.

The exact dose, frequency, and duration of treatment are determined by the prescribing clinician based on the specific condition, severity, patient age, and other individual factors. Patients should follow the prescriber’s instructions and not alter the regimen without medical advice.

Safety data for topical metronidazole in pregnancy and lactation are limited. It should be used only if the potential benefit justifies any possible risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss the treatment with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide. After the request, the sales team will verify trade or institutional credentials and respond with pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Metronidazole differs from many topical antibiotics because it targets anaerobic organisms and protozoa through DNA damage rather than inhibiting cell‑wall synthesis. It is especially effective for inflammatory lesions of rosacea, whereas agents like clindamycin primarily address acne‑related bacteria. Choice of therapy depends on the underlying pathogen, clinical presentation and physician preference.

Store the product below 25 °C in its original packaging, protecting it from moisture and direct light. Keep the container tightly closed when not in use. Do not freeze or expose the medication to extreme temperatures, as this could affect its stability and efficacy.

The medication is applied topically to the affected skin area, usually once or twice daily, as directed by a healthcare professional. Clean and gently pat the skin dry before applying a thin layer of the product. Avoid contact with eyes, mucous membranes, and broken skin unless specifically instructed.

Serious adverse reactions, although rare, include severe allergic responses such as swelling, hives, or difficulty breathing, and severe skin conditions like Stevens‑Johnson syndrome. Neurological symptoms such as peripheral neuropathy or dizziness may also occur. If any of these signs develop, discontinue use and seek immediate medical attention.

Patients with a known hypersensitivity to metronidazole or any component of the formulation should avoid its use. Individuals with severe liver impairment should use it only under close medical supervision. Pregnant or breastfeeding women should only use it if the prescriber determines that the benefits outweigh potential risks.